147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Applications
Therapy areas
NORMAL SEARCH
ADVANCED SEARCH
More posts
BIO21066-D1

Methods of determining whether a patient suffering froma

Pheochromocytomas produce and store catecholamines. The release of excessive amounts of catecholamine can lead to life-threatening […]

Read more

You might also be interested in

MK123-T2

Testsynchrotheracrm1904

TestsynchroPATENTCRM1904 […]

Read more
BIO22037-R1

Cd38 as a biomarker and biotarget in

Lorem ipsum […]

Read more
BIO16235-T1

Methods of enhancing the potency of incretin-based

The present invention relates to methods of enhancing the potency of incretin-based drugs in […]

Read more
BIO13310-T1

Apelin analogs for the treatment of heart failure

The invention related to metabolically stable Apelin analogs and their use for the prevention or the […]

Read more
BIO13410-T1

Monoacylglycerol lipase as target for the

The present invention relates to methods and pharmaceutical compositions for the treatment of […]

Read more
BIO07572-T1

Treatment of bone mineral density related diseases

The present invention relates to methods of the treatment and diagnosis of bone mineral density […]

Read more
BIO17663-T1

Methods and compositions for treating skin

The present invention relates to a method for treating skin afflictions in a subject comprising a […]

Read more
BIO18503-T1

Use of coumarin derivatives for the preparation of

Kallikrein proteolytic cascade plays a crucial role in various skin diseases. A series of coumarinic […]

Read more
BIO16366-R1

Ctip fusion to cas9 enhances transgene integration

The present invention relates to nuclease protein fusions for enhancing genome editing by […]

Read more
BIO19413-D1

Methods and compositions for treating cell

The inventors have surprisingly demonstrated that GD3 positive senescent cells inhibit NK cell in […]

Read more
BIO2002601-D1

In vitro tests allowing to identify the potential

TP53 mutations are the most frequent mutations in all cancer subtypes and their acquisition are key […]

Read more
BIO21080-D1

Methods for prognosis, stratification and

In the present invention inventors used measured cytokine levels in serum of patients with COVID-19, […]

Read more